BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 22846726)

  • 1. Guillain-Barré syndrome incidence in a large United States cohort (2000-2009).
    Shui IM; Rett MD; Weintraub E; Marcy M; Amato AA; Sheikh SI; Ho D; Lee GM; Yih WK;
    Neuroepidemiology; 2012; 39(2):109-15. PubMed ID: 22846726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estimation of background incidence rates of Guillain-Barré syndrome in Germany - a retrospective cohort study with electronic healthcare data.
    Hense S; Schink T; Kreisel SH; Marcelon L; Simondon F; Tahden M; Garbe E
    Neuroepidemiology; 2014; 43(3-4):244-52. PubMed ID: 25531827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Guillain-Barré syndrome: background incidence rates in The Netherlands.
    van der Maas NA; Kramer MA; Jacobs BC; van Soest EM; Dieleman JP; Kemmeren JM; de Melker HE; Sturkenboom MC
    J Peripher Nerv Syst; 2011 Sep; 16(3):243-9. PubMed ID: 22003939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A 15-Year Nationwide Epidemiological Analysis of Guillain-Barré Syndrome in Taiwan.
    Huang WC; Lu CL; Chen SC
    Neuroepidemiology; 2015; 44(4):249-54. PubMed ID: 26088600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence of Guillain-Barré syndrome in Sweden 1996.
    Cheng Q; Jiang GX; Fredrikson S; Link H; De Pedro-Cuesta J
    Eur J Neurol; 2000 Jan; 7(1):11-6. PubMed ID: 10809910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Population incidence of Guillain-Barré syndrome in parts of China: three large populations in Jiangsu province, 2008-2010.
    Chen Y; Ma F; Zhang J; Chu X; Xu Y
    Eur J Neurol; 2014; 21(1):124-9. PubMed ID: 24102733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Guillain-Barré syndrome: incidence and mortality rates in US hospitals.
    Alshekhlee A; Hussain Z; Sultan B; Katirji B
    Neurology; 2008 Apr; 70(18):1608-13. PubMed ID: 18443311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Guillain-Barré syndrome in the northern area of Gran Canaria and the island of Lanzarote].
    Aladro-Benito Y; Conde-Sendin MA; Muñoz-Fernández C; Pérez-Correa S; Alemany-Rodríguez MJ; Fiuza-Pérez MD; Alamo-Santana F
    Rev Neurol; 2002 Oct 16-31; 35(8):705-10. PubMed ID: 12402219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hospital admissions for Guillain-Barré syndrome in the United States, 1993-2004.
    Frenzen PD
    Neuroepidemiology; 2007; 29(1-2):83-8. PubMed ID: 17925599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pediatric Guillain-Barré Syndrome in a 30-Year Nationwide Cohort.
    Levison LS; Thomsen RW; Markvardsen LK; Christensen DH; Sindrup SH; Andersen H
    Pediatr Neurol; 2020 Jun; 107():57-63. PubMed ID: 32192820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Guillain-Barré syndrome after vaccination in United States: data from the Centers for Disease Control and Prevention/Food and Drug Administration Vaccine Adverse Event Reporting System (1990-2005).
    Souayah N; Nasar A; Suri MF; Qureshi AI
    J Clin Neuromuscul Dis; 2009 Sep; 11(1):1-6. PubMed ID: 19730016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Guillain-Barré syndrome in France: a nationwide epidemiological analysis based on hospital discharge data (2008-2013).
    Delannoy A; Rudant J; Chaignot C; Bolgert F; Mikaeloff Y; Weill A
    J Peripher Nerv Syst; 2017 Mar; 22(1):51-58. PubMed ID: 27991707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Guillain-Barré syndrome in northwest Greece.
    Markoula S; Giannopoulos S; Sarmas I; Tzavidi S; Kyritsis AP; Lagos G
    Acta Neurol Scand; 2007 Mar; 115(3):167-73. PubMed ID: 17295711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Epidemiological characteristics of Guillain-Barré syndrome in urban and rural areas in Beijing and Hebei, China].
    Hong X; Zhang Z; Wang J; Zhang B; Yin W; Zhang X; Tang X; Guo Y
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2000 Apr; 22(2):115-9. PubMed ID: 12903510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence and clinical features of acute inflammatory polyradiculoneuropathy in Lombardy, Italy, 1996.
    Bogliun G; Beghi E;
    Acta Neurol Scand; 2004 Aug; 110(2):100-6. PubMed ID: 15242417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. No association between immunization and Guillain-Barré syndrome in the United Kingdom, 1992 to 2000.
    Hughes RA; Charlton J; Latinovic R; Gulliford MC
    Arch Intern Med; 2006 Jun; 166(12):1301-4. PubMed ID: 16801513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low back pain in the United States: incidence and risk factors for presentation in the emergency setting.
    Waterman BR; Belmont PJ; Schoenfeld AJ
    Spine J; 2012 Jan; 12(1):63-70. PubMed ID: 21978519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence of
    Scallan Walter EJ; Crim SM; Bruce BB; Griffin PM
    Foodborne Pathog Dis; 2020 Jan; 17(1):23-28. PubMed ID: 31509036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between occurrence of Guillain-Barre syndrome and mass campaign of measles and rubella immunization in Iranian 5-14 years old children.
    Esteghamati A; Gouya MM; Keshtkar AA; Mahoney F
    Vaccine; 2008 Sep; 26(39):5058-61. PubMed ID: 18662736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preliminary results: surveillance for Guillain-Barré syndrome after receipt of influenza A (H1N1) 2009 monovalent vaccine - United States, 2009-2010.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2010 Jun; 59(21):657-61. PubMed ID: 20520590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.